defective breast implants

Breast Implants Linked to Rare Cancer

Read about the recent HSE announcement relating to Allergan Biocell breast implants

* In contentious business, a solicitor may not calculate fees or other charges as a percentage or proportion of any award or settlement.
© 2023 Ivor Fitzpatrick & Company Solicitors | Contact Us | Privacy & Cookie Statement

Privacy Preferences

When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.

You have read and agreed to our privacy policy

Required

I agree with the storage and handling of my data by Ivor Fitzpatrick & Company Solicitors for the purposes of contacting me.
Please leave this field empty.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

disable

Please enable Strictly Necessary Cookies first so that we can save your preferences!